Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06168461 · ClinicalTrials.gov registry record · Early Phase 1
Daily Aspirin Treatment After Preeclampsia
A Early Phase 1 study of Preeclampsia, sponsored by Anna Stanhewicz, PhD.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06168461 is a Early Phase 1 study of Preeclampsia that is actively recruiting participants, run by Anna Stanhewicz, PhD. The registered enrollment target is 40 participants, below the 1,281-participant average among 39 other Preeclampsia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06168461, a Early Phase 1 study of Preeclampsia, is actively recruiting participants, sponsored by Anna Stanhewicz, PhD.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Women who develop preeclampsia during pregnancy are four times more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs may be related to lasting blood vessel damage after the pregnancy but there are currently no specific treatment strategies to prevent this disease progression. This study addresses this public health issue by examining whether starting low dose aspirin therapy after pregnancy is an effective treatment for lasting blood vessel damage in order to inform better clinical management of cardiovascular disease risk in women who have had preeclampsia.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Aspirin
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06168461
The ClinicalTrials.gov registry entry for NCT06168461 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,281-participant average among 39 other Preeclampsia trials with a reported enrollment target (97% lower). The listed sponsor is Anna Stanhewicz, PhD, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preeclampsia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06168461 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT06168461 about?
NCT06168461 is a clinical study titled "Daily Aspirin Treatment After Preeclampsia". Women who develop preeclampsia during pregnancy are four times more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs may be related to lasting blood vessel damage after the pregnancy but there are currently no specific treatment s...
What is the current status of trial NCT06168461?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2023-11-01. Estimated completion is 2026-06.
What conditions does trial NCT06168461 study?
This clinical trial studies the following conditions: Preeclampsia.
What interventions are being tested in trial NCT06168461?
The interventions under investigation include: Placebo (DRUG), Aspirin (DRUG).
Who is sponsoring clinical trial NCT06168461?
This trial is sponsored by Anna Stanhewicz, PhD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06168461 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
-
Predictors of Aspirin Failure in Preeclampsia Prevention
RECRUITING · Early Phase 1
-
Vascular Effects of High-Salt After Preeclampsia
RECRUITING · Early Phase 1
-
MR and Inflammation After Preeclampsia
ACTIVE NOT RECRUITING · Early Phase 1
-
Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)
COMPLETED · Early Phase 1
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.